Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marco A. Coccia"'
Autor:
Marco A. Coccia, Patricia McElroy, Graham Molineux, Weston Sutherland, Juan Del Castillo, John E. Tarpley, Jeanne Pistillo, Cynthia Hartley
Publikováno v:
Experimental Hematology. 29:59-67
Therapeutic use of recombinant human cytokines in humans can result in the generation of drug-specific antibodies. To predetermine the maximum potential effects of a granulocyte colony-stimulating factor (G-CSF) neutralizing auto-immunoglobulin G (au
Autor:
Michael G. Sonnenberg, Kent Miner, Ariela Hui, Raffi Manoukian, John M. Delaney, Ming Zhang, Marco A. Coccia, Hong Han, Tom Horan, John Whoriskey, Jeanne Pistillo, Steven Kiyoshi Yoshinaga, Sanjay D. Khare, Tianang Dai, Tom Boone, David W. Brankow, Tadahiko Kohno
Publikováno v:
International Immunology. 12:1439-1447
Optimal T cell activation requires the interactions of co-stimulatory molecules, such as those in the CD28 and B7 protein families. Recently, we described the co-stimulatory properties of the murine ligand to ICOS, which we designated as B7RP-1. Here
Autor:
Gary Elliott, Grace Shih, Ming Zhang, Gwyneth Van, Pauline Campbell, Christine L. Shaklee, Tak W. Mak, John Whoriskey, Ulla Sarmiento, Jane Guo, Tadahiko Kohno, David Chang, Ariela Hui, Marco A. Coccia, Tom Horan, Tianang Dai, Anna Tafuri-Bladt, Laura Chiu, Giorgio Senaldi, Sheila Scully, David W. Brankow, Susan McCabe, Gordon S. Duncan, Steven Kiyoshi Yoshinaga, Sanjay D. Khare, Arda Shahinian
Publikováno v:
Nature. 402:827-832
T-cell activation requires co-stimulation through receptors such as CD28 and antigen-specific signalling through the T-cell antigen receptor. Here we describe a new murine costimulatory receptor-ligand pair. The receptor, which is related to CD28 and
Autor:
Marco A. Coccia, Peter Brams
Publikováno v:
The Journal of Immunology. 161:5772-5780
We report here that immunization of human PBMC reconstituted SCID mice (hu-PBL-SCID mice) with in vitro cultured autologous dendritic cells (DC) pulsed with prostate specific antigen (PSA) complexed to a PSA-specific mouse IgG2a (PSA-IgG2a) consisten
Publikováno v:
Immunobiology. 198:396-407
The SCIDhu PBL model of human Ig production was modified by using human interleukin-6 (hIL-6) secreting tumors for continuous hIL-6 production, in vivo . On day one, SCID mice were injected subcutaneously with 200 µl PBS (control mice), 10 4 SP2/0-A
Autor:
Keegan Cooke, Juan Del Castillo, G Stoney, Jeanne Pistillo, Marco A. Coccia, Graham Molineux, Diane Duryea, John E. Tarpley
Publikováno v:
Experimental hematology. 29(10)
Objective We developed a rodent model of noninfectious systemic inflammation to examine the pathogenesis of the associated anemia of chronic disorders (ACD), to evaluate the similarity of this ACD model to human ACD, and to evaluate the potential eff
Autor:
J. Del Castillo, Marco A. Coccia, Jeanne Pistillo, Graham Molineux, Keegan Cooke, G Stoney, Weston Sutherland
Publikováno v:
Speaker abstracts 2001.
Background We previously reported that ARANESP™ alleviates ACD in a rodent model of peptidoglycan-polysaccharide polymer (PG-APS) mediated inflammation. We report here the further characterisation of this model and the effects of ARANESP™ treatme
Autor:
Alan J. Korman, Marco A. Coccia, Mark J. Selby, Hadia Lemar, Ben Preston, Diane Feingersh, Alison Witte, Jon Terrett
Publikováno v:
Clinical Immunology. 123:S121-S122
Publikováno v:
Hybridoma. 17(1)
Traditional hybridoma fusion technology requires complete medium with serum supplements to support the growth of hybridoma cells. Serum is also required for subcloning of hybridoma cells to support low density cell growth. IL-6 has been shown to enha
Autor:
Mohan Srinivasan, Albert Assad, Robert F. Graziano, Sharline Chen, David Passmore, Michelle R. Kuhne, Ben Preston, Pina M. Cardarelli, Tseng-Hui Chen, Cristina Loomis, David J. King, Marco A. Coccia, Alison Witte, Jie Liu, Amelia Black
Publikováno v:
Blood. 112:1580-1580
Therapeutic monoclonal antibodies kill target cells by multiple mechanisms including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent phagocytosis (ADP), complement-dependent cytotoxicity (CDC), and direct induction of apoptosis. A